The role of amyloidogenic protein oligomerization in neurodegenerative disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of molecular medicine

• Publication date

  2013-03-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00109-013-1025-1PMID 23529761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Therapeutic Antibody Targeting Bace1 Inhibits Amyloid-beta Production in Vivo

  2013cited by this paper
• Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

  2012cited by this paper
• DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau.

  2012cited by this paper
• Serine phosphorylation suppresses huntingtin amyloid accumulation by altering protein aggregation properties.

  2012cited by this paper
• Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.

  2012cited by this paper
• Alzheimer's disease market: hope deferred

  2012cited by this paper
• Impaired Heat Shock Response in Cells Expressing Full-Length Polyglutamine-Expanded Huntingtin

  2012cited by this paper
• Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

  2012cited by this paper
• The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

  2012cited by this paper
• Protein aggregates in Huntington's disease.

  2012cited by this paper
• Prion-like acceleration of a synucleinopathy in a transgenic mouse model.

  2012cited by this paper
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012cited by this paper
• Tafamidis for transthyretin amyloidosis.

  2012cited by this paper
• Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity.

  2012cited by this paper
• Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical development.

  2012cited by this paper
• Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

  2012cited by this paper
• Tafamidis for transthyretin amyloidosis.

  2012cited by this paper
• Fragments of HdhQ150 Mutant Huntingtin Form a Soluble Oligomer Pool That Declines with Aggregate Deposition upon Aging

  2012cited by this paper
• Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions

  2012cited by this paper
• SUPPLEMENTARY INFORMATION Identifying polyglutamine protein species in situ that best predict neurodegeneration

  2011cited by this paper
• The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption.

  2011cited by this paper
• A Screen for Enhancers of Clearance Identifies Huntingtin as a Heat Shock Protein 90 (Hsp90) Client Protein*

  2011cited by this paper
• S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain

  2011cited by this paper
• A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo

  2011cited by this paper
• In vivo demonstration that α-synuclein oligomers are toxic

  2011cited by this paper
• P4‐316: Stabilization of neurotoxic Alzheimer amyloid‐beta oligomers by protein engineering

  2011cited by this paper
• Protein homeostasis and aging: The importance of exquisite quality control.

  2011cited by this paper
• Disease-modifying treatments for Alzheimer’s disease

  2011cited by this paper
• Identifying polyglutamine protein species in situ that best predict neurodegeneration

  2011cited by this paper
• Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions.

  2011cited by this paper
• Aberrant protein interactions in amyloid disease

  2011cited by this paper
• Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?

  2011cited by this paper
• Point mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces.

  2011cited by this paper
• The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities.

  2011cited by this paper
• Oligonucleotide therapeutic approaches for Huntington disease.

  2011cited by this paper
• Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease.

  2011cited by this paper
• CARGO RECOGNITION FAILURE IS RESPONSIBLE FOR INEFFICIENT AUTOPHAGY IN HUNTINGTON’S DISEASE

  2010cited by this paper
• Acetylation of tau inhibits its degradation and contributes to tauopathy.

  2010cited by this paper
• The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?

  2010cited by this paper
• Huntington disease

  2010cited by this paper
• Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease*

  2010cited by this paper
• Electrical coupling between olfactory glomeruli.

  2010cited by this paper
• Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine Length-dependent Manner in Vitro and in Vivo*

  2010cited by this paper
• Tau in Alzheimer disease and related tauopathies.

  2010cited by this paper
• Molecular chaperones as rational drug targets for Parkinson's disease therapeutics.

  2010cited by this paper
• A causative link between the structure of aberrant protein oligomers and their toxicity.

  2010cited by this paper
• Amyloid oligomers: formation and toxicity of Aβ oligomers

  2010cited by this paper
• Chaperone networks: tipping the balance in protein folding diseases.

  2010cited by this paper
• Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers

  2010cited by this paper
• Countering amyloid polymorphism and drug resistance with minimal drug cocktails

  2010cited by this paper
• Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated.

  2010cited by this paper
• Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle*

  2010cited by this paper
• Neurotoxic protein oligomerisation associated with polyglutamine diseases

  2010cited by this paper
• ANS binding reveals common features of cytotoxic amyloid species.

  2010cited by this paper
• Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering

  2010cited by this paper
• Tracking Mutant Huntingtin Aggregation Kinetics in Cells Reveals Three Major Populations That Include an Invariant Oligomer Pool*

  2010cited by this paper
• Glimpses of the molecular mechanisms of β2-microglobulin fibril formation in vitro: Aggregation on a complex energy landscape

  2009cited by this paper
• Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.

  2009cited by this paper
• Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer*

  2009cited by this paper
• Polyglutamine disruption of the huntingtin exon1 N-terminus triggers a complex aggregation mechanism

  2009cited by this paper
• The Shock of Aging: Molecular Chaperones and the Heat Shock Response in Longevity and Aging – A Mini-Review

  2009cited by this paper
• Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.

  2009cited by this paper
• Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells*

  2009cited by this paper
• A synergistic small molecule combination directly eradicates diverse prion strain structures

  2009cited by this paper
• Transmission and spreading of tauopathy in transgenic mouse brain

  2009cited by this paper
• The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases

  2008cited by this paper
• Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice

  2008cited by this paper
• Hope in Alzheimer's fight emerges from unexpected places

  2008influential reference
• Adapting Proteostasis for Disease Intervention

  2008cited by this paper
• Direct characterization of amyloidogenic oligomers by single-molecule fluorescence

  2008cited by this paper
• Structural Classification of Toxic Amyloid Oligomers*

  2008influential reference
• Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies

  2008cited by this paper
• Global changes to the ubiquitin system in Huntington's disease

  2007cited by this paper
• Polymorphism in the intermediates and products of amyloid assembly.

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Focality of upper and lower motor neuron degeneration at the clinical onset of ALS

  2007cited by this paper
• Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.

  2007cited by this paper
• Molecular chaperone‐mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain

  2007cited by this paper
• Generic Cell Dysfunction in Neurodegenerative Disorders: Role of Surfaces in Early Protein Misfolding, Aggregation, and Aggregate Cytotoxicity

  2007cited by this paper
• Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils

  2007cited by this paper
• Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid

  2007cited by this paper
• Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis

  2006cited by this paper
• Inhibition of protein misfolding and aggregation by small rationally-designed peptides.

  2006cited by this paper
• Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Protein misfolding, functional amyloid, and human disease.

  2006cited by this paper
• Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons*

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• The physical basis of how prion conformations determine strain phenotypes

  2006cited by this paper
• Progressive Disruption of Cellular Protein Folding in Models of Polyglutamine Diseases

  2006cited by this paper
• Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease.

  2006cited by this paper
• Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases.

  2006cited by this paper
• Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

  2006cited by this paper
• 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration

  2005cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila.

  2005cited by this paper
• Modulation of neurodegeneration by molecular chaperones

  2005cited by this paper
• Amyloid ion channels: a common structural link for protein-misfolding disease.

  2005cited by this paper
• Neurogenetics: insights into degenerative diseases and approaches to schizophrenia

  2005cited by this paper
• Mechanisms of Suppression of α-Synuclein Neurotoxicity by Geldanamycin in Drosophila*

  2005cited by this paper

• Amyloidogenic SARS-CoV-2 Spike Protein-Derived Peptides Form Oligomers and Selectively Damage Lipid Membranes.

  2025cites this paper
• Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies

  2025cites this paper
• Critical aggregation concentration and reversibility of amyloid-β (1-40) oligomers.

  2024cites this paper
• Excipient Induced Unusual Phase Separation in Bovine Serum Albumin Solution: An Explicit Role Played by Ion-Hydration.

  2024cites this paper
• Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer’s Disease

  2023cites this paper
• Biopolymers as promising vehicles for drug delivery to the brain

  2023cites this paper
• Lipid binding properties of huntingtin as a novel therapeutic target

  2023cites this paper
• How Single Site Mutations Can Help Understanding Structure Formation of Amyloid β1-40.

  2023cites this paper
• The current state of amyloidosis therapeutics and the potential role of fluorine in their treatment.

  2022cites this paper
• Physicochemical Properties Altered by the Tail Group of Lipid Membranes Influence Huntingtin Aggregation and Lipid Binding.

  2022cites this paper
• The effect of stress on biophysical characteristics of misfolded protein aggregates in living Saccharomyces cerevisiae cells.

  2022cites this paper
• Understanding and controlling amyloid aggregation with chirality.

  2021cites this paper
• Peptide backbone modifications of amyloid β (1–40) impact fibrillation behavior and neuronal toxicity

  2021cites this paper
• The potential anti‐amyloidogenic candidate, SPA1413, for Alzheimer's disease

  2021cites this paper
• Protein Aggregation Patterns Inform about Breast Cancer Response to Antiestrogens and Reveal the RNA Ligase RTCB as Mediator of Acquired Tamoxifen Resistance

  2021cites this paper
• SUMOylation prevents huntingtin fibrillization and localization onto lipid membranes.

  2019cites this paper
• Lipid membranes influence the ability of small molecules to inhibit huntingtin fibrillization.

  2019cites this paper
• Why Aβ42 Is Much More Toxic than Aβ40.

  2019cites this paper
• The impact of self-replicating proteins on inflammation, autoimmunity and neurodegeneration-An untraveled path.

  2019cites this paper
• Length-Dependent Manifestation of Vibration Modes Regulates a Specific Intermediate Morphology of Aβ17-42 in Different Environments.

  2018cites this paper
• Oligomerization of yeast prion Sup35NM

  2018cites this paper
• Sphingomyelin and GM1 Influence Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes

  2018cites this paper
• Why Abeta42 Is Much More Toxic Than Abeta40.

  2018cites this paper
• Effect of Varying Concentrations of Docosahexaenoic Acid on Amyloid Beta (1–42) Aggregation: An Atomic Force Microscopy Study

  2018cites this paper
• Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.

  2017cites this paper
• Amyloid β-Sheet Secondary Structure Identified in UV-Induced Cataracts of Porcine Lenses using 2D IR Spectroscopy.

  2017cites this paper
• AmyPro: a database of proteins with validated amyloidogenic regions

  2017cites this paper
• Quantitative Study of the Oligomerization of Yeast Prion Sup35NM Proteins.

  2017cites this paper
• Molecular Dynamics Investigations of Structural Conversions in Transformer Proteins

  2017cites this paper
• Polyalanine expansions drive a shift into -helical clusters without amyloid fibril formation.

  2016cites this paper
• Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington’s disease model system

  2016cites this paper
• Effects of Trehalose on Thermodynamic Properties of Alpha-synuclein Revealed through Synchrotron Radiation Circular Dichroism

  2015cites this paper
• Polyalanine expansions drive a shift into α-helical clusters without amyloid-fibril formation

  2015cites this paper
• Assembly and Disassembly of Protein Aggregates

  2015cites this paper
• Standardization and quality control in quantifying non-enzymatic oxidative protein modifications in relation to ageing and disease: Why is it important and why is it hard?

  2015cites this paper
• Targeting Assembly and Disassembly of Protein Aggregates

  2015cites this paper
• Peptides as modulators of α-synuclein aggregation.

  2015cites this paper
• Thermodynamic description of Beta amyloid formation using physicochemical scales and fractal bioinformatic scales.

  2015cites this paper
• Preparation protocols of aβ(1-40) promote the formation of polymorphic aggregates and altered interactions with lipid bilayers.

  2014cites this paper
• Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis.

  2014cites this paper
• Misfolded Polyglutamine, Polyalanine, and Superoxide Dismutase 1 Aggregate via Distinct Pathways in the Cell*

  2014cites this paper
• Distinct Pathways in the Cell Superoxide Dismutase 1 Aggregate via Misfolded Polyglutamine , Polyalanine , and Molecular Bases of Disease :

  2014cites this paper
• Evaluation of Nanoparticle Tracking for Characterization of Fibrillar Protein Aggregates.

  2014cites this paper
• Molecular dynamics investigations of the α-helix to β-barrel conformational transformation in the RfaH transcription factor.

  2014cites this paper
• Understanding neuronal dysfunction and loss in neurodegenerative disease

  2013cites this paper
• MODULATION OF ALPHA-SYNUCLEIN PROTEIN FOLDING BY A MARINE-SOURCED EXTRACT

  2013cites this paper
• Thermodynamic Description of Beta Amyloid Formation

  2013cites this paper
• On the subject of rigor in the study of amyloid β-protein assembly

  2013cites this paper
• Dévelopement d'une méthode bio-informatique pour la prédiction des régions amyloidogéniques dans les protéines.

  2013influential citation